Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Hematopoietic progenitor cell marrow therapy - Ossium Health

Next Previous
X
Search
Drug Profile

Hematopoietic progenitor cell marrow therapy - Ossium Health

Alternative Names: HPC marrow

Latest Information Update: 07 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ossium Health
  • Class Antineoplastics; Haematopoietic stem cells therapies; Immunotherapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Transplant rejection
  • Phase I/II Acute biphenotypic leukaemia; Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Preclinical Graft-versus-host disease

Most Recent Events

  • 07 Oct 2024 Ossium Health and Biomedical Advanced Research and Development Authority agree to collaborate for Hematopoietic progenitor cell marrow therapy for Acute Radiation Syndrome in USA
  • 17 Sep 2024 Preliminary efficacy and adverse events data from a phase I/II PRESERVE 1 trial in Acute myeloid leukemia released by Ossium Health
  • 30 Jun 2024 Ossium Health and Henry Ford Health agree to collaborate for Hematopoietic progenitor cell marrow therapy in USA for Acute myeloid leukrmia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top